NCT02801305View on ClinicalTrials.gov

Diltiazem Gel Versus Nitroglycerin Ointment in Healing Process of Scleroderma Digital Ulcers

PHASE2CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

June 30, 2016

Primary Completion Date

January 31, 2017

Study Completion Date

March 31, 2017

Conditions
Digital Ulcer of Scleroderma
Interventions
DRUG

Diltiazem Gel 2%

This a topical agent which will be applied on digital ulcers by scleroderma patients.

DRUG

Nitroglycerin Ointment 2%

This a topical agent which will be applied on digital ulcers by scleroderma patients.

DRUG

Vaseline

This is used as the topical placebo agent.

Trial Locations (1)

Unknown

Rheumatology Reseach Center, Shiraz University of Medical Sciences, Shiraz, Iran., Shiraz

All Listed Sponsors
collaborator

Shiraz University of Medical Sciences

OTHER

lead

Mohammad Ali Nazarinia

OTHER

NCT02801305 - Diltiazem Gel Versus Nitroglycerin Ointment in Healing Process of Scleroderma Digital Ulcers | Biotech Hunter | Biotech Hunter